AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. NKTR
  4. [SCHEDULE 13G/A] Nektar Therapeutics SEC Filing

[SCHEDULE 13G/A] Nektar Therapeutics SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Filing content is currently unavailable.

Source:

Stock NKTR logo
Nektar Therapeutics

NASDAQ:NKTR

NKTR Rankings

#3014 Ranked by Market Cap
N/A Ranked by Dividends

NKTR Latest News

Sep 3, 2025
Nektar Therapeutics to Participate in Two Investor Conferences in September
Aug 7, 2025
Nektar Therapeutics Reports Second Quarter 2025 Financial Results
Jul 31, 2025
Nektar to Announce Financial Results for the Second Quarter on Thursday, August 7, 2025, After Close of U.S.-Based Financial Markets
Jul 29, 2025
Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Severe-to-Very Severe Alopecia Areata
Jul 2, 2025
Nektar Therapeutics Announces Closing of $115 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares

NKTR Latest SEC Filings

Sep 5, 2025
[144] Nektar Therapeutics SEC Filing
Sep 4, 2025
[Form 4] Nektar Therapeutics Insider Trading Activity
Sep 4, 2025
[Form 4] Nektar Therapeutics Insider Trading Activity
Sep 4, 2025
[144] Nektar Therapeutics SEC Filing
Sep 4, 2025
[144] Nektar Therapeutics SEC Filing

NKTR Stock Data

684.29M
18.86M
0.83%
47.51%
5.93%
Biotechnology
Pharmaceutical Preparations
United States
SAN FRANCISCO